Replimune Group, Inc. · NASDAQ:REPL
Xynos Konstantinos received 50,000 Replimune Group, Inc. shares as an award (Form 4)
Traded Apr 1, 2026 · Filed Apr 7, 2026
On Apr 1, 2026, Xynos Konstantinos (Chief Medical Officer) received 50,000 Replimune Group, Inc. shares as an award, leaving 249,685 shares. Filed Apr 7, 2026 (Form 4).
- Awarded
- 50,000 shares
- Holding after
- 249,685 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | Award | 50,000 | 249,685 | Direct |
Source
Related
- Replimune Group, Inc.
- Xynos Konstantinos
- Replimune Group, Inc. shareholders
- Form 4 · Xynos Konstantinos · Aug 12, 2026
- Form 4 · Xynos Konstantinos · May 20, 2026
- Form 4 · Astley-Sparke Philip · Aug 24, 2026
- Form 4 · Hill Emily Luisa · Aug 19, 2026
- Schedule 13G/A · Ridgeback Capital Investments L.P. · Aug 14, 2026
- Form 4 · Patel Sushil · Aug 12, 2026
- Form 4 · Hill Emily Luisa · Aug 12, 2026